(Q40404841)

20 September 2017

title

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease (English)

1 reference

20 September 2017

1 reference

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Stéphane Chauvie

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Francesca Gay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Barbara Gamberi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Massimo Offidani

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Michele Balma

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Katia Mancuso

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

Antonia Dimitrakopoulou-Strauss

5 June 2020

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Stefano Fanti

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Michele Cavo

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

E Zamagni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

C Nanni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A Pezzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

F Patriarca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M Bellò

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

I Rambaldi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

P Tacchetti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

J Hillengass

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

L Pantani

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

V Magarotto

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A Versari

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

B Zannetti

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

F Carobolante

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M Rensi

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

S Rocchi

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

N Fard

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

G Marzocchi

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

G Storto

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

P Ghedini

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A Palumbo

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

22 October 2015

1 reference

20 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

417-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

New criteria for response assessment: role of minimal residual disease in multiple myeloma

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

International uniform response criteria for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Dilemmas in treating smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Diagnosis of smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

How I treat smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Smoldering multiple myeloma: natural history and recognition of an evolving type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

21 January 2018

1 reference

12 December 2020

The role of imaging techniques in the management of multiple myeloma

1 reference

12 December 2020

Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

1 reference

12 December 2020

Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients

1 reference

12 December 2020

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma

1 reference

12 December 2020

Treatment for High-Risk Smoldering Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.291

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/LEU.2015.291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 June 2020

1024919571

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26490489%20AND%20SRC:MED&resulttype=core&format=json